Phase I Study Photodynamic Therapy Using Lutrin (Lutetium Texaphyrin) in the Treatment of Patients With Cervical Intraepithelial Neoplasia

Trial Profile

Phase I Study Photodynamic Therapy Using Lutrin (Lutetium Texaphyrin) in the Treatment of Patients With Cervical Intraepithelial Neoplasia

Discontinued
Phase of Trial: Phase I

Latest Information Update: 06 Feb 2013

At a glance

  • Drugs Motexafin lutetium (Primary)
  • Indications Cervical cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Feb 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 29 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top